234 related articles for article (PubMed ID: 23796203)
1. Commentary on "Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder." Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy: BJU Int 2012;110(6 Pt B):E222-7 [Epub 2012 Feb 7].
Kamat AM
Urol Oncol; 2013 Jul; 31(5):718-9. PubMed ID: 23796203
[TBL] [Abstract][Full Text] [Related]
2. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Martini T; Lodde M; Pycha A; Comploj E; Wieland WF; Denzinger S; Otto W; Burger M; Fritsche HM
BJU Int; 2012 Sep; 110(6 Pt B):E222-7. PubMed ID: 22314129
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Martini T; Lodde M; Comploj E; Pycha A; Strobel J; Denzinger S; Otto W; Wieland W; Burger M; Fritsche HM
Eur Urol; 2012 Oct; 62(4):662-70. PubMed ID: 22534059
[TBL] [Abstract][Full Text] [Related]
5. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
6. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
[TBL] [Abstract][Full Text] [Related]
7. The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Burger M; Martini T; Pycha A; Dechet C; Lodde M; Comploj E; Wieland WF; Denzinger S; Otto W; Aziz A; Fritsche HM; Gierth M
Urol Int; 2014; 93(3):303-10. PubMed ID: 25139069
[TBL] [Abstract][Full Text] [Related]
8. Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy.
Novotny V; Froehner M; Koch R; Zastrow S; Heberling U; Leike S; Hübler M; Wirth MP
World J Urol; 2016 Aug; 34(8):1123-9. PubMed ID: 26658887
[TBL] [Abstract][Full Text] [Related]
9. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
Koppie TM; Serio AM; Vickers AJ; Vora K; Dalbagni G; Donat SM; Herr HW; Bochner BH
Cancer; 2008 Jun; 112(11):2384-92. PubMed ID: 18404699
[TBL] [Abstract][Full Text] [Related]
10. Restrictive transfusion in radical cystectomy is safe.
Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S
Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
[TBL] [Abstract][Full Text] [Related]
11. Does patient age affect survival after radical cystectomy?
Horovitz D; Turker P; Bostrom PJ; Mirtti T; Nurmi M; Kuk C; Kulkarni G; Fleshner NE; Finelli A; Jewett MA; Zlotta AR
BJU Int; 2012 Dec; 110(11 Pt B):E486-93. PubMed ID: 22551360
[TBL] [Abstract][Full Text] [Related]
12. Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.
Froehner M; Koch R; Hübler M; Heberling U; Novotny V; Zastrow S; Hakenberg OW; Wirth MP
BMC Urol; 2018 Oct; 18(1):91. PubMed ID: 30348141
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
14. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder].
May M; Fritsche HM; Gilfrich C; Brookman-May S; Burger M; Otto W; Bolenz C; Trojan L; Herrmann E; Michel MS; Wülfing C; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Müller O; Bretschneider-Ehrenberg P; Zacharias M; Gunia S; Bastian PJ
Urologe A; 2011 Jul; 50(7):821-9. PubMed ID: 21340593
[TBL] [Abstract][Full Text] [Related]
15. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
[TBL] [Abstract][Full Text] [Related]
16. The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer.
Djaladat H; Bruins HM; Miranda G; Cai J; Skinner EC; Daneshmand S
BJU Int; 2014 Jun; 113(6):887-93. PubMed ID: 23906037
[TBL] [Abstract][Full Text] [Related]
17. [Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer].
Mayr R; Pycha A
Aktuelle Urol; 2015 May; 46(3):236-41. PubMed ID: 26077308
[TBL] [Abstract][Full Text] [Related]
18. Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy.
Roghmann F; Trinh QD; Braun K; von Bodman C; Brock M; Noldus J; Palisaar J
Int J Urol; 2014 Feb; 21(2):143-9. PubMed ID: 23906282
[TBL] [Abstract][Full Text] [Related]
19. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
